Xiangtan Electrochemical Scientific Co.,Ltd (SHE:002125)
China · Delayed Price · Currency is CNY 15.60
0.00 (0.00%)
May 7, 2026, 3:04 PM CST
SHE:002125 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,923 | 1,921 | 1,882 | 2,128 | 1,928 | 1,410 |
Other Revenue | - | - | 30.39 | 35.15 | 171.99 | 461.19 |
| 1,923 | 1,921 | 1,912 | 2,163 | 2,100 | 1,872 | |
Revenue Growth (YoY) | -2.43% | 0.46% | -11.60% | 3.01% | 12.22% | 51.64% |
Cost of Revenue | 1,535 | 1,507 | 1,405 | 1,706 | 1,559 | 1,506 |
Gross Profit | 388.05 | 414.5 | 507.81 | 457.58 | 540.91 | 365.92 |
Selling, General & Admin | 126.83 | 129.32 | 131.46 | 115.57 | 166.5 | 100.26 |
Research & Development | 78.06 | 80.03 | 70.37 | 63.18 | 58.71 | 32.39 |
Other Operating Expenses | 15.24 | 14.82 | 16.24 | 11.93 | 15.48 | 17.53 |
Operating Expenses | 221.28 | 224.18 | 181.71 | 153.77 | 320.65 | 181.5 |
Operating Income | 166.78 | 190.32 | 326.1 | 303.8 | 220.25 | 184.42 |
Interest Expense | -2.02 | - | -38.19 | -51.29 | -60.6 | -64.91 |
Interest & Investment Income | 170.68 | 100.85 | 54.5 | 105.5 | 253.21 | 105.25 |
Currency Exchange Gain (Loss) | - | - | 4.06 | 3 | 13.7 | -4.95 |
Other Non Operating Income (Expenses) | -47.4 | -44.48 | -0.21 | -0.3 | -2.94 | -3.09 |
EBT Excluding Unusual Items | 288.03 | 246.7 | 346.25 | 360.72 | 423.63 | 216.7 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.12 | 19.41 | -0.01 | 187.09 |
Asset Writedown | -2.44 | -0.06 | 6.91 | 0.22 | -5.41 | -119.66 |
Other Unusual Items | - | - | 2.65 | 5.7 | 9.4 | 6.51 |
Pretax Income | 285.58 | 246.63 | 355.94 | 386.04 | 427.61 | 290.65 |
Income Tax Expense | 29.93 | 31.79 | 50.91 | 45.79 | 24.1 | 36.11 |
Earnings From Continuing Operations | 255.65 | 214.84 | 305.03 | 340.25 | 403.51 | 254.53 |
Minority Interest in Earnings | 11.82 | 10.61 | 9.98 | 12.08 | -9.29 | -16.77 |
Net Income | 267.47 | 225.45 | 315.01 | 352.33 | 394.22 | 237.76 |
Net Income to Common | 267.47 | 225.45 | 315.01 | 352.33 | 394.22 | 237.76 |
Net Income Growth | -14.76% | -28.43% | -10.59% | -10.63% | 65.81% | 839.82% |
Shares Outstanding (Basic) | 638 | 626 | 630 | 629 | 626 | 626 |
Shares Outstanding (Diluted) | 656 | 644 | 630 | 629 | 626 | 626 |
Shares Change (YoY) | 4.73% | 2.24% | 0.14% | 0.55% | 0.01% | -1.07% |
EPS (Basic) | 0.42 | 0.36 | 0.50 | 0.56 | 0.63 | 0.38 |
EPS (Diluted) | 0.41 | 0.35 | 0.50 | 0.56 | 0.63 | 0.38 |
EPS Growth | -18.61% | -30.00% | -10.71% | -11.11% | 65.79% | 850.00% |
Free Cash Flow | 251.81 | 158.68 | 286.18 | 295.33 | 55.53 | -159.93 |
Free Cash Flow Per Share | 0.38 | 0.25 | 0.45 | 0.47 | 0.09 | -0.26 |
Dividend Per Share | - | - | 0.160 | 0.168 | 0.126 | 0.050 |
Dividend Growth | - | - | -4.76% | 33.33% | 152.00% | 150.00% |
Gross Margin | 20.18% | 21.57% | 26.55% | 21.15% | 25.75% | 19.55% |
Operating Margin | 8.67% | 9.91% | 17.05% | 14.04% | 10.49% | 9.85% |
Profit Margin | 13.91% | 11.73% | 16.47% | 16.29% | 18.77% | 12.70% |
Free Cash Flow Margin | 13.10% | 8.26% | 14.96% | 13.65% | 2.64% | -8.55% |
EBITDA | 371.25 | 393.73 | 525.22 | 499.77 | 391.28 | 339.19 |
EBITDA Margin | 19.31% | 20.49% | 27.46% | 23.10% | 18.63% | 18.12% |
D&A For EBITDA | 204.48 | 203.41 | 199.12 | 195.97 | 171.03 | 154.77 |
EBIT | 166.78 | 190.32 | 326.1 | 303.8 | 220.25 | 184.42 |
EBIT Margin | 8.67% | 9.91% | 17.05% | 14.04% | 10.49% | 9.85% |
Effective Tax Rate | 10.48% | 12.89% | 14.30% | 11.86% | 5.64% | 12.43% |
Revenue as Reported | 1.39 | - | 1,912 | 2,163 | 2,100 | 1,872 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.